TERRASCEND CORP (TSND.CA) Stock Fundamental Analysis
Canada - TSX:TSND - CA88105E1088 - Common Stock
0.95 CAD
-0.19 (-16.67%)
TSND gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 31 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of TSND have multiple concerns. TSND is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
TSND had negative earnings in the past year.
In the past year TSND had a positive cash flow from operations.
In the past 5 years TSND reported 4 times negative net income.
In multiple years TSND reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -13.33%, TSND is doing worse than 61.29% of the companies in the same industry.
Looking at the Return On Equity, with a value of -64.65%, TSND is doing worse than 64.52% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.28%, TSND is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.33% | ||
| ROE | -64.65% | ||
| ROIC | 4.28% |
ROA(3y)-24.86%
ROA(5y)-21.32%
ROE(3y)-62.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TSND has a Operating Margin of 10.26%. This is amongst the best in the industry. TSND outperforms 83.87% of its industry peers.
TSND's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 50.46%, TSND is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
In the last couple of years the Gross Margin of TSND has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.26% | ||
| PM (TTM) | N/A | ||
| GM | 50.46% |
OM growth 3Y-5.82%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.82%
GM growth 5Y37.79%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TSND is destroying value.
TSND has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TSND has more shares outstanding
The debt/assets ratio for TSND is higher compared to a year ago.
2.2 Solvency
TSND has an Altman-Z score of -0.95. This is a bad value and indicates that TSND is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TSND (-0.95) is comparable to the rest of the industry.
TSND has a debt to FCF ratio of 18.35. This is a negative value and a sign of low solvency as TSND would need 18.35 years to pay back of all of its debts.
TSND has a Debt to FCF ratio of 18.35. This is in the better half of the industry: TSND outperforms 67.74% of its industry peers.
TSND has a Debt/Equity ratio of 1.77. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of TSND (1.77) is worse than 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.77 | ||
| Debt/FCF | 18.35 | ||
| Altman-Z | -0.95 |
ROIC/WACC0.46
WACC9.34%
2.3 Liquidity
A Current Ratio of 1.45 indicates that TSND should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.45, TSND is doing worse than 64.52% of the companies in the same industry.
TSND has a Quick Ratio of 1.07. This is a normal value and indicates that TSND is financially healthy and should not expect problems in meeting its short term obligations.
TSND's Quick ratio of 1.07 is in line compared to the rest of the industry. TSND outperforms 41.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.45 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
The earnings per share for TSND have decreased strongly by -12.50% in the last year.
TSND shows a decrease in Revenue. In the last year, the revenue decreased by -3.36%.
TSND shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.80% yearly.
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y13.38%
Revenue growth 5Y36.8%
Sales Q2Q%-12.23%
3.2 Future
TSND is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.08% yearly.
TSND is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.60% yearly.
EPS Next Y55.61%
EPS Next 2Y34.23%
EPS Next 3Y23.57%
EPS Next 5Y13.08%
Revenue Next Year-13.46%
Revenue Next 2Y-4.77%
Revenue Next 3Y-0.82%
Revenue Next 5Y2.6%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for TSND. In the last year negative earnings were reported.
Also next year TSND is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TSND indicates a somewhat cheap valuation: TSND is cheaper than 77.42% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, TSND is valued a bit cheaper than the industry average as 67.74% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.9 | ||
| EV/EBITDA | 8.94 |
4.3 Compensation for Growth
TSND's earnings are expected to grow with 23.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.23%
EPS Next 3Y23.57%
5. Dividend
5.1 Amount
No dividends for TSND!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:TSND (11/12/2025, 7:00:00 PM)
0.95
-0.19 (-16.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners35.45%
Inst Owner ChangeN/A
Ins Owners5.91%
Ins Owner ChangeN/A
Market Cap351.25M
Revenue(TTM)306.68M
Net Income(TTM)-76.25M
Analysts82.22
Price Target1.96 (106.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-317.53%
Min EPS beat(2)-614.39%
Max EPS beat(2)-20.66%
EPS beat(4)0
Avg EPS beat(4)-243.78%
Min EPS beat(4)-614.39%
Max EPS beat(4)-20.66%
EPS beat(8)0
Avg EPS beat(8)-269.57%
EPS beat(12)1
Avg EPS beat(12)-371.5%
EPS beat(16)3
Avg EPS beat(16)-184.77%
Revenue beat(2)0
Avg Revenue beat(2)-4.7%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-3.26%
Revenue beat(4)0
Avg Revenue beat(4)-4.36%
Min Revenue beat(4)-6.15%
Max Revenue beat(4)-2.6%
Revenue beat(8)1
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-3.34%
Revenue beat(16)2
Avg Revenue beat(16)-6.24%
PT rev (1m)2.22%
PT rev (3m)2.22%
EPS NQ rev (1m)-4.98%
EPS NQ rev (3m)24.99%
EPS NY rev (1m)16.07%
EPS NY rev (3m)-15.2%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-11.48%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)-9.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.88 | ||
| P/FCF | 21.9 | ||
| P/OCF | 11.19 | ||
| P/B | 2.12 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.94 |
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.04
FCFY4.57%
OCF(TTM)0.08
OCFY8.94%
SpS1.08
BVpS0.45
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.33% | ||
| ROE | -64.65% | ||
| ROCE | 6.07% | ||
| ROIC | 4.28% | ||
| ROICexc | 4.54% | ||
| ROICexgc | 11.68% | ||
| OM | 10.26% | ||
| PM (TTM) | N/A | ||
| GM | 50.46% | ||
| FCFM | 4.02% |
ROA(3y)-24.86%
ROA(5y)-21.32%
ROE(3y)-62.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-2.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y1.66%
ROICexc growth 5YN/A
OM growth 3Y-5.82%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.82%
GM growth 5Y37.79%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.77 | ||
| Debt/FCF | 18.35 | ||
| Debt/EBITDA | 4.25 | ||
| Cap/Depr | 54.65% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 1.19 | ||
| Cash Conversion | 45.49% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.45 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | -0.95 |
F-Score4
WACC9.34%
ROIC/WACC0.46
Cap/Depr(3y)90.87%
Cap/Depr(5y)192.32%
Cap/Sales(3y)7.77%
Cap/Sales(5y)14.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y55.61%
EPS Next 2Y34.23%
EPS Next 3Y23.57%
EPS Next 5Y13.08%
Revenue 1Y (TTM)-3.36%
Revenue growth 3Y13.38%
Revenue growth 5Y36.8%
Sales Q2Q%-12.23%
Revenue Next Year-13.46%
Revenue Next 2Y-4.77%
Revenue Next 3Y-0.82%
Revenue Next 5Y2.6%
EBIT growth 1Y-37.21%
EBIT growth 3Y6.79%
EBIT growth 5YN/A
EBIT Next Year160.07%
EBIT Next 3Y44.3%
EBIT Next 5Y30.79%
FCF growth 1Y177.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.53%
OCF growth 3YN/A
OCF growth 5YN/A
TERRASCEND CORP / TSND.CA FAQ
What is the fundamental rating for TSND stock?
ChartMill assigns a fundamental rating of 3 / 10 to TSND.CA.
What is the valuation status for TSND stock?
ChartMill assigns a valuation rating of 2 / 10 to TERRASCEND CORP (TSND.CA). This can be considered as Overvalued.
What is the profitability of TSND stock?
TERRASCEND CORP (TSND.CA) has a profitability rating of 3 / 10.
What is the financial health of TERRASCEND CORP (TSND.CA) stock?
The financial health rating of TERRASCEND CORP (TSND.CA) is 2 / 10.